StartDate,EndDate,Status,IPAddress,Progress,Duration (in seconds),Finished,RecordedDate,ResponseId,RecipientLastName,RecipientFirstName,RecipientEmail,ExternalReference,LocationLatitude,LocationLongitude,DistributionChannel,UserLanguage,Q1,Q17,Q15,Q7,Q8,Q9,Q10,Q11,Q12,Q13,Q14,Q18,11,Login ID
Start Date,End Date,Response Type,IP Address,Progress,Duration (in seconds),Finished,Recorded Date,Response ID,Recipient Last Name,Recipient First Name,Recipient Email,External Data Reference,Location Latitude,Location Longitude,Distribution Channel,User Language,Name of Key Program,Acronym for key program,Focus Area (select all that apply),DOC,Primary Contact (PI),Primary Contact (PI) email,NIH Contact (Program Officer/Program Director),NIH Contact (Program Officer/Program Director) email,"NOFO number (eg. format as ""RFA-CA-00-000"") (If more than one, separate with ; semicolon)","Grant/Award number {parent award FORMAT LL#CA######, eg. UG3CA260607} (If more than one, separate with ; semicolon)",Link to program website,Link to data or DCC if available,"What type of cancer is the primary focus of the program? (Check all that
apply)",Login ID
"{""ImportId"":""startDate"",""timeZone"":""America/Denver""}","{""ImportId"":""endDate"",""timeZone"":""America/Denver""}","{""ImportId"":""status""}","{""ImportId"":""ipAddress""}","{""ImportId"":""progress""}","{""ImportId"":""duration""}","{""ImportId"":""finished""}","{""ImportId"":""recordedDate"",""timeZone"":""America/Denver""}","{""ImportId"":""_recordId""}","{""ImportId"":""recipientLastName""}","{""ImportId"":""recipientFirstName""}","{""ImportId"":""recipientEmail""}","{""ImportId"":""externalDataReference""}","{""ImportId"":""locationLatitude""}","{""ImportId"":""locationLongitude""}","{""ImportId"":""distributionChannel""}","{""ImportId"":""userLanguage""}","{""ImportId"":""QID1_TEXT""}","{""ImportId"":""QID17_TEXT""}","{""ImportId"":""QID15""}","{""ImportId"":""QID7""}","{""ImportId"":""QID8_TEXT""}","{""ImportId"":""QID9_TEXT""}","{""ImportId"":""QID10_TEXT""}","{""ImportId"":""QID11_TEXT""}","{""ImportId"":""QID12_TEXT""}","{""ImportId"":""QID13_TEXT""}","{""ImportId"":""QID14_TEXT""}","{""ImportId"":""QID18_TEXT""}","{""ImportId"":""QID16""}","{""ImportId"":""Login ID""}"
7/18/2023 14:13,7/18/2023 14:13,IP Address,73.130.95.160,100,19,TRUE,7/18/2023 14:13,R_3MaFUlwsb4dImG3,,,,,40.0756,-76.6914,anonymous,EN,Cellular Cancer Biology Imaging Research,CCBIR,,DCB,"PROVENZANO, PAOLO; BACKMAN, VADIM; WIRTZ, DENIS; DANUSER, GAUDENZ",pprovenz@umn.edu; v-backman@northwestern.edu; WIRTZ@JHU.EDU; gaudenz.danuser@utsouthwestern.edu,"BECKER, STEVEN",beckersteven@mail.nih.gov,RFA-CA-21-002,,https://www.cancer.gov/about-nci/organization/dcb/research-programs/ccbir,,This program focuses on cancer broadly - not limited to a primary cancer type,375764
7/18/2023 14:19,7/18/2023 14:25,IP Address,73.130.95.160,100,313,TRUE,7/18/2023 14:25,R_3nJjmwcTmfe9Ws9,,,,,40.0756,-76.6914,anonymous,EN,Barrettâ€™s Esophagus Translational Research Network (BETRNet),BETRNet,"DCC,Clinical Networks",DCP,,,"RICHMOND, ELLEN S.; YASSIN, RIHAB R.",er115z@nih.gov; ry38k@nih.gov,RFA-CA-16-007; RFA-CA-16-006; RFA-CA-10-014,,https://prevention.cancer.gov/major-programs/barretts-esophagus-translational-research-network-betrnet,,Esophageal Cancer,935250
7/18/2023 14:25,7/18/2023 14:29,IP Address,73.130.95.160,100,186,TRUE,7/18/2023 14:29,R_2P5yBZSEWW19Gb7,,,,,40.0756,-76.6914,anonymous,EN,Fusion Oncoproteins in Childhood Cancers (FusOnc2),FusOnc2,"Pediatric/AYA,Cancer Moonshot",DCB,"Keren Witkin, Ph.D.",witkinkeren@mail.nih.gov,"Smith,Malcolm",Malcolm.Smith@nih.gov,RFA-CA-17-049;RFA-CA-19-016,,https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/implementation/childhood-cancer-research#fusion-oncoproteins-in-childhood-cancers-fusonc2-consortium,,This program focuses on cancer broadly - not limited to a primary cancer type,699612
7/18/2023 14:30,7/18/2023 14:41,IP Address,73.130.95.160,100,680,TRUE,7/18/2023 14:41,R_b29WNmDDM4Nhd7j,,,,,40.0756,-76.6914,anonymous,EN,The Early Detection Research Network (EDRN),EDRN,"DCC,Clinical Networks",DCP,,,"MARQUEZ, GUILLERMO; SORBARA, LYNN R",gm186p@nih.gov; lynns@mail.nih.gov,CA-14-017;CA-21-034;CA-21-033;CA-21-035;CA-14-015;CA-14-016;CA-16-009,,https://edrn.nci.nih.gov/,https://edrn.nci.nih.gov/data-and-resources/data/,This program focuses on cancer broadly - not limited to a primary cancer type,190484
7/18/2023 14:43,7/18/2023 14:44,IP Address,73.130.95.160,100,43,TRUE,7/18/2023 14:44,R_0pT1g50QqcEx2VP,,,,,40.0756,-76.6914,anonymous,EN,Cancer Prevention-Interception Targeted Agent Discovery Program,CAP-IT,DCC,DCP,,,"Sei, Shizuko",shizuko.sei@nih.gov,RFA-CA-21-038;RFA-CA-22-055;RFA-CA-21-039,,https://prevention.cancer.gov/major-programs/cancer-prevention-interception-targeted-agent-discovery-program,,This program focuses on cancer broadly - not limited to a primary cancer type,556874
7/18/2023 14:50,7/18/2023 14:51,IP Address,73.130.95.160,100,74,TRUE,7/18/2023 14:51,R_1mn63oTMgOgaGLV,,,,,40.0756,-76.6914,anonymous,EN,Small Cell Lung Cancer (SCLC) Consortium,SCLC,DCC,DCP,,,"UJHAZY, PETER",ujhazyp@mail.nih.gov,PAR21-346;PAR-16-049;PAR-16-050;PAR-16-051;PAR-19-361,,https://prevention.cancer.gov/major-programs/small-cell-lung-cancer-sclc-consortium,,Lung Cancer,583289
7/19/2023 4:23,7/19/2023 4:24,IP Address,73.130.95.160,100,61,TRUE,7/19/2023 4:24,R_10ShVDjfZKG1iO1,,,,,40.0756,-76.6914,anonymous,EN,Acquired Resistance to Therapy Network (ARTNet),ARTNet,"DCC,Cancer Moonshot,Clinical Networks",DCTD,,,"hildesheim, jeff",hildesheimj@mail.nih.gov,RFA-CA-21-052;RFA-CA-21-053,,https://www.cancer.gov/about-nci/organization/dcb/research-programs/artnet,,This program focuses on cancer broadly - not limited to a primary cancer type,359379
7/19/2023 6:10,7/19/2023 6:14,IP Address,73.130.95.160,100,240,TRUE,7/19/2023 6:14,R_pRbO7oRZoez5KZX,,,,,40.0756,-76.6914,anonymous,EN,SPORE in Bladder Cancer,SPORE in Bladder Cancer,SPORE,DCTD,"BAJORIN, DEAN F",,"Arnold, Julia T",jarnold@mail.nih.gov,,P50CA221745,https://trp.cancer.gov/spores/abstracts/mskcc_bladder.htm,,Bladder Cancer,845567
7/19/2023 6:16,7/19/2023 6:18,IP Address,73.130.95.160,100,106,TRUE,7/19/2023 6:18,R_2sbv9jTFo4jcizx,,,,,40.0756,-76.6914,anonymous,EN,SPORE: Targeted Therapies for Glioma,SPORE: Targeted Therapies for Glioma,SPORE,DCTD,"BATCHELOR, TRACY T",,"Hubbard, Leah",leah.hubbard@nih.gov,,P50CA165962,https://trp.cancer.gov/spores/abstracts/brigham_and_women_brain.htm,,Brain Cancer,222153
7/19/2023 6:18,7/19/2023 6:21,IP Address,73.130.95.160,100,174,TRUE,7/19/2023 6:21,R_21swLXgVTdJgCnK,,,,,40.0756,-76.6914,anonymous,EN,The Memorial Sloan Kettering Cancer Center SPORE in Leukemia,SPORE in Leukemia,SPORE,DCTD,"ABDEL-WAHAB, OMAR ",,"Kuzmin, Igor A",kuzmini@mail.nih.gov,,P50CA254838,https://trp.cancer.gov/spores/abstracts/mskcc_leukemia.htm,,Leukemia,496118
7/19/2023 6:21,7/19/2023 6:25,IP Address,73.130.95.160,100,256,TRUE,7/19/2023 6:25,R_2QgnKbIl7sNPFex,,,,,40.0756,-76.6914,anonymous,EN,The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma,SPORE in Hepatocellular Carcinoma,SPORE,DCTD,"BERETTA, LAURA ",,"Nothwehr, Steven F",steve.nothwehr@nih.gov,,P50CA217674,https://trp.cancer.gov/spores/abstracts/mdanderson_hepatobiliary.htm,,Liver Cancer,401600
7/19/2023 6:26,7/19/2023 6:28,IP Address,73.130.95.160,100,95,TRUE,7/19/2023 6:28,R_31m7Y86MxwUhSxO,,,,,40.0756,-76.6914,anonymous,EN,Brain Tumor SPORE Grant,Brain Tumor SPORE Grant,SPORE,DCTD,"BERGER, MITCHEL S",,"Hubbard, Leah",leah.hubbard@nih.gov,,P50CA097257,,,Brain Cancer,983163
7/19/2023 6:31,7/19/2023 6:33,IP Address,73.130.95.160,100,82,TRUE,7/19/2023 6:33,R_1n9MOthlZcO8D6V,,,,,40.0756,-76.6914,anonymous,EN,Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal Cancer,SPORE in Gastrointestinal Cancer,SPORE,DCTD,"COFFEY, ROBERT J",,"Nothwehr, Steven F",steve.nothwehr@nih.gov,,P50CA236733,https://trp.cancer.gov/spores/abstracts/vanderbilt_gi.htm,,Gastric Cancer,577760
7/19/2023 6:33,7/19/2023 6:35,IP Address,73.130.95.160,100,113,TRUE,7/19/2023 6:35,R_2dSG7gooOD4FVys,,,,,40.0756,-76.6914,anonymous,EN,ADMIRAL Study: Admixture analysis of acute lymphoblastic leukemia in African American children,ADMIRAL,"Pediatric/AYA,Health Disparities",DCCPS,Logan Spector Ph.D.,spect012@umn.edu,Danielle L. Daee Ph.D.,danielle.daee@nih.gov,,R01CA239701,https://maps.cancer.gov/overview/DCCPSGrants/abstract.jsp?applId=9995648&term=CA239701,,Leukemia,939152
7/19/2023 6:38,7/19/2023 6:39,IP Address,73.130.95.160,100,84,TRUE,7/19/2023 6:39,R_ALnFESNYVkKRMUV,,,,,40.0756,-76.6914,anonymous,EN,SPORE in Myeloid Malignancies,SPORE in Myeloid Malignancies,SPORE,DCTD,"EBERT, BENJAMIN LEVINE",,"Kuzmin, Igor A",kuzmini@mail.nih.gov,,P50CA206963,https://trp.cancer.gov/spores/abstracts/brigham_and_women_leukemia.htm,,"Leukemia,Multiple Myeloma",274321
7/19/2023 6:39,7/19/2023 6:42,IP Address,73.130.95.160,100,165,TRUE,7/19/2023 6:42,R_sGzyt7s7P8zrXZT,,,,,40.0756,-76.6914,anonymous,EN,Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer,SPORE in Lung Cancer - Yale,SPORE,DCTD,"HERBST, ROY S",,"Ujhazy, Peter",ujhazyp@mail.nih.gov,,P50CA196530,https://trp.cancer.gov/spores/abstracts/yale_lung.htm,,Lung Cancer,257027
7/19/2023 6:42,7/19/2023 6:43,IP Address,73.130.95.160,100,75,TRUE,7/19/2023 6:43,R_2EcLTONQeGMNGRq,,,,,40.0756,-76.6914,anonymous,EN,Fred Hutchinson Cancer Research Center Lung SPORE,SPORE in Lung Cancer - Fred Hutch,SPORE,DCTD,"HOUGHTON, A MCGARRY",,"Ujhazy, Peter",ujhazyp@mail.nih.gov,,P50CA228944,,https://trp.cancer.gov/spores/abstracts/fhcrc_lung.htm,Lung Cancer,229394
7/27/2023 6:27,7/27/2023 6:52,IP Address,73.130.95.160,100,1497,TRUE,7/27/2023 6:52,R_1ITd7QI7z9Pv4CM,,,,,40.0756,-76.6914,anonymous,EN,Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS),ACCSIS,"DCC,Cancer Moonshot",DCCPS,,,"GRIMES, GENEVIEVE M",medleyge@mail.nih.gov,CA17-039;CA-17-038;CA-19-018,,https://healthcaredelivery.cancer.gov/accsis/,https://accsis.rti.org/consortium/cc/,Colorectal Cancer,896721
7/27/2023 8:38,7/27/2023 8:43,IP Address,73.130.95.160,100,258,TRUE,7/27/2023 8:43,R_3EWKDAnuokJbods,,,,,40.0756,-76.6914,anonymous,EN,SPORE University of Texas M. D. Anderson Cancer Center-Leukemia,SPORE Leukemia - Texas,SPORE,DCTD,,,"Kuzmin, Igor A",kuzmini@mail.nih.gov,,P50CA100632,https://trp.cancer.gov/spores/abstracts/mdanderson_leukemia.htm,,Leukemia,329254
7/27/2023 8:43,7/27/2023 8:53,IP Address,73.130.95.160,100,600,TRUE,7/27/2023 8:53,R_3D5rqshFxhwqxGz,,,,,40.0756,-76.6914,anonymous,EN,MD Anderson Cancer Center SPORE in Gastrointestinal Cancer,SPORE Gastrointestinal Cancer,SPORE,DCTD,,,"Nothwehr, Steven F",steve.nothwehr@nih.gov,,P50CA221707,https://trp.cancer.gov/spores/abstracts/mdanderson_gi.htm,,Gastric Cancer,671542
7/27/2023 8:54,7/27/2023 8:54,IP Address,73.130.95.160,100,49,TRUE,7/27/2023 8:54,R_21thwgoPN3KuxSS,,,,,40.0756,-76.6914,anonymous,EN,University of Texas SPORE in Brain Cancer,SPORE Brain Cancer - Texas,SPORE,DCTD,,,"Hubbard, Leah",leah.hubbard@nih.gov,,P50CA127001,https://trp.cancer.gov/spores/abstracts/mdanderson_brain.htm,,Brain Cancer,506222
7/27/2023 8:55,7/27/2023 8:59,IP Address,73.130.95.160,100,278,TRUE,7/27/2023 8:59,R_3mn6dvjnjBjnuIg,,,,,40.0756,-76.6914,anonymous,EN,SPORE for Translational Approaches to Brain Cancer,SPORE Brain Cancer - Northwestern,SPORE,DCTD,,,"Hubbard, Leah",leah.hubbard@nih.gov,,P50CA221747,https://trp.cancer.gov/spores/abstracts/northwestern_brain.htm,,Brain Cancer,820057
7/27/2023 8:59,7/27/2023 9:27,IP Address,73.130.95.160,100,1639,TRUE,7/27/2023 9:27,R_1gd1ouYsabNUXEr,,,,,40.0756,-76.6914,anonymous,EN,Specialized Program Of Research Excellence (SPORE) in Leukemia.,SPORE Leukemia - WashU,SPORE,DCTD,,,"Kuzmin, Igor A",kuzmini@mail.nih.gov,,P50CA171963,https://trp.cancer.gov/spores/abstracts/wustl_leukemia.htm,,Leukemia,377806
7/27/2023 9:28,7/27/2023 9:46,IP Address,73.130.95.160,100,1065,TRUE,7/27/2023 9:46,R_bezRRmDhcnoLaMh,,,,,40.0756,-76.6914,anonymous,EN,Mayo Clinic Hepatobiliary SPORE,SPORE Liver,SPORE,DCTD,,,"Nothwehr, Steven F",steve.nothwehr@nih.gov,,P50CA210964,https://trp.cancer.gov/spores/abstracts/mayo_hepatobiliary.htm,,Liver Cancer,966534
7/27/2023 9:50,7/27/2023 9:51,IP Address,73.130.95.160,100,61,TRUE,7/27/2023 9:51,R_3snBgzxSfgZdFfR,,,,,40.0756,-76.6914,anonymous,EN,Dana-Farber/Harvard Cancer Center Kidney Cancer SPORE,SPORE Kidney Cancer,SPORE,DCTD,,,"Kuzmin, Igor A",kuzmini@mail.nih.gov,,P50CA101942,https://trp.cancer.gov/spores/abstracts/dfhcc_gu.htm,,Kidney Cancer,622983
7/27/2023 9:54,7/27/2023 9:56,IP Address,73.130.95.160,100,116,TRUE,7/27/2023 9:56,R_3JDVtoGLP1CNN3c,,,,,40.0756,-76.6914,anonymous,EN,University of Texas SPORE in Lung Cancer,SPORE Lung Cancer - Texas,SPORE,DCTD,,,"Ujhazy, Peter",ujhazyp@mail.nih.gov,,P50CA070907,https://trp.cancer.gov/spores/abstracts/utsouthwestern_lung.htm,,Lung Cancer,323763
7/27/2023 9:58,7/27/2023 9:59,IP Address,73.130.95.160,100,55,TRUE,7/27/2023 9:59,R_3k5qBQqZZXIQoCz,,,,,40.0756,-76.6914,anonymous,EN,University of North Carolina SPORE in Breast Cancer,SPORE Breast Cancer - UNC,SPORE,DCTD,,,"COURTNEY, JOYANN",joyann.rohan@nih.gov,,P50CA058223,https://trp.cancer.gov/spores/abstracts/unc_breast.htm,,Breast Cancer,832201
7/27/2023 14:07,7/27/2023 14:09,IP Address,73.130.95.160,100,102,TRUE,7/27/2023 14:09,R_3QJoOJTO8k0wEUZ,,,,,40.0756,-76.6914,anonymous,EN,Vanderbilt University SPORE in Breast Cancer,SPORE Breast Cancer - Vanderbilt,SPORE,DCTD,,,"COURTNEY, JOYANN",joyann.rohan@nih.gov,,P50CA098131,https://trp.cancer.gov/spores/abstracts/vanderbilt_breast.htm,,Breast Cancer,547116
7/27/2023 14:11,7/27/2023 14:12,IP Address,73.130.95.160,100,49,TRUE,7/27/2023 14:12,R_1rNvZXFyOgtXvyg,,,,,40.0756,-76.6914,anonymous,EN,MSK SPORE in Genomic Instability in Breast Cancer,SPORE Breast Cancer - MSK,SPORE,DCTD,,,"BASA JANAKIRAM, NAVEENA",naveena.basajanakiram@nih.gov,,P50CA247749,https://trp.cancer.gov/spores/abstracts/mskcc_breast.htm,,Breast Cancer,164365
7/27/2023 14:12,7/27/2023 14:13,IP Address,73.130.95.160,100,78,TRUE,7/27/2023 14:13,R_2UXdEnG2K5eCG27,,,,,40.0756,-76.6914,anonymous,EN,Emory University Lung Cancer SPORE,SPORE Lung Cancer - Emory,SPORE,DCTD,,,"Ujhazy, Peter",ujhazyp@mail.nih.gov,,P50CA217691,https://trp.cancer.gov/spores/abstracts/emory_lung.htm,,Lung Cancer,915446
7/27/2023 14:18,7/27/2023 14:18,IP Address,73.130.95.160,100,21,TRUE,7/27/2023 14:18,R_3fIhwcuR1thu5Y9,,,,,40.0756,-76.6914,anonymous,EN,Epigenetic Therapies - New Approaches,SPORE Epigenetics,SPORE,DCTD,,,"Ujhazy, Peter",ujhazyp@mail.nih.gov,,P50CA254897,https://trp.cancer.gov/spores/abstracts/coriell_institute_epigenetics.htm,,This program focuses on cancer broadly - not limited to a primary cancer type,832927
7/27/2023 14:19,7/27/2023 14:19,IP Address,73.130.95.160,100,25,TRUE,7/27/2023 14:19,R_1l4NJY9fKEJXqBY,,,,,40.0756,-76.6914,anonymous,EN,SPORE in Gastrointestinal Cancers,SPORE Gastrointestinal,SPORE,DCTD,,,"Nothwehr, Steven F",steve.nothwehr@nih.gov,,P50CA062924,https://trp.cancer.gov/spores/abstracts/johnshopkins_gi.htm,,Gastric Cancer,160265
7/28/2023 5:40,7/28/2023 5:41,IP Address,73.130.95.160,100,81,TRUE,7/28/2023 5:41,R_1iafUCZHmPcRLV6,,,,,40.0756,-76.6914,anonymous,EN,Improving Management of Symptoms Across Cancer Treatments,IMPACT,"DCC,Cancer Moonshot,Clinical Networks",DCCPS,,,"ADAMS, LYNN S",lynn.adams@nih.gov,CA17-043;CA-17-042,,https://healthcaredelivery.cancer.gov/impact/,,This program focuses on cancer broadly - not limited to a primary cancer type,221562
7/28/2023 5:41,7/28/2023 5:47,IP Address,73.130.95.160,100,384,TRUE,7/28/2023 5:47,R_3saIUbovDZASObG,,,,,40.0756,-76.6914,anonymous,EN,CONSORTIUM FOR PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) TRANSLATIONAL STUDIES,PDAC Consortium,"DCC,Cancer Moonshot",DCP,,,"UJHAZY, PETER",ujhazyp@mail.nih.gov,CA-17-015;CA-17-016,,https://prevention.cancer.gov/major-programs/pancreatic-cancer-detection-consortium-pcdc/pcdc-teams/mayo-clinic-rochester-university-pennsylvania,,Pancreas Cancer,740409
7/28/2023 5:47,7/28/2023 6:36,IP Address,73.130.95.160,100,2908,TRUE,7/28/2023 6:36,R_3rNuH4E8rYh4XMo,,,,,40.0756,-76.6914,anonymous,EN,A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research,CIBMTR (Data Resource),"DCC,Clinical Networks",DCTD,,,"HOROWITZ, MARY MARESCA",marymh@mcw.edu,CA-12-503;CA-17-031;CA-22-026,,https://cibmtr.org/CIBMTR/Resources/Publicly-Available-Datasets#,,"This program focuses on cancer broadly - not limited to a primary cancer type,Leukemia,Lymphoma",842044
7/28/2023 16:07,7/28/2023 16:44,IP Address,128.231.234.24,100,2254,TRUE,7/28/2023 16:44,R_2bHSExcQptQqAvu,,,,,39.0462,-77.1195,anonymous,EN,Partnerships to Advance Cancer Health Equity (PACHE),PACHE,"Cancer Center,Health Disparities",CRCHD,,,"Rodriguez, Laritza; Wali, Anil; Davani, Behrous ",laritza.rodriguez@nih.gov; walia@mail.nih.gov; behrous.davani@nih.gov,RFA-PAR-18-767; RFA-PAR-22-249; RFA-PAR-22-239; RFA-PAR-18-911; RFA-PAR-18-361,,https://www.cancer.gov/about-nci/organization/crchd/diversity-training/pache,,This program focuses on cancer broadly - not limited to a primary cancer type,960497
7/31/2023 9:31,7/31/2023 10:44,IP Address,128.231.234.20,100,4398,TRUE,7/31/2023 10:44,R_1BVldgCxHAnJ4iJ,,,,,39.0462,-77.1195,anonymous,EN,Genomic Data Analysis Network,GDAN,DCC,CCG,,,"LIMING, YANG",lyang@mail.nih.gov,RFA-CA-20-053; RFA-CA-15-020; RFA-CA-15-019; RFA-CA-15-018,,https://docs.gdc.cancer.gov/Encyclopedia/pages/Genomic_Data_Analysis_Network/,,This program focuses on cancer broadly - not limited to a primary cancer type,418400
7/31/2023 14:19,7/31/2023 15:56,IP Address,128.231.234.21,100,5815,TRUE,7/31/2023 15:56,R_SMCAKBwydscaYCJ,,,,,39.0462,-77.1195,anonymous,EN,Cancer Systems Biology Consortium (CSBC),CSBC,"DCC,Clinical Networks",DCB,,,"Dueck, Hannah; Zamisch, Monica; HUGHES, SHANNON K",hannah.dueck@nih.gov; monica.zamisch@nih.gov; shannon.hughes@nih.gov,RFA-CA-15-015; RFA-CA-21-049; RFA-CA-21-048; RFA-CA-15-014; PAR-16-131; PAR-19-287,,https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc/cancer-systems-biology-consortium,,This program focuses on cancer broadly - not limited to a primary cancer type,945750
8/1/2023 5:38,8/1/2023 5:40,IP Address,73.130.95.160,100,108,TRUE,8/1/2023 5:40,R_OjyS5M37C165F7j,,,,,40.0756,-76.6914,anonymous,EN,Development and Expansion of Digital Tools to Support Smoking Cessation,C3I,Cancer Moonshot,DCCPS,,,"Vandor, Stacey",vandors@mail.nih.gov,,26114002B91019F00132-0-0-1,https://cancercontrol.cancer.gov/brp/tcrb/cancer-center-cessation-initiative,,This program focuses on cancer broadly - not limited to a primary cancer type,720371
8/1/2023 5:40,8/1/2023 7:24,IP Address,73.130.95.160,100,6270,TRUE,8/1/2023 7:24,R_XvyAFR3tOX4II9z,,,,,40.0756,-76.6914,anonymous,EN,THE CHERNOBYL TISSUE BANK - COORDINATING CENTER,THE CHERNOBYL TISSUE BANK - COORDINATING CENTER,"DCC,Clinical Networks",DCEG,,,"YASSIN, RIHAB R.",ry38k@nih.gov,CA16-502;CA12-501,,https://www.chernobyltissuebank.com/,,Thyroid Cancer,190427
8/1/2023 10:14,8/1/2023 11:01,IP Address,128.231.234.24,100,2857,TRUE,8/1/2023 11:01,R_e2OdFH0DK3tI7GF,,,,,39.0462,-77.1195,anonymous,EN,Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes,ENICTO,"DCC,Clinical Networks",DCCPS,"Evans, Scott; Robien, Kim",sevans@bsc.gwu.edu; krobien@gwu.edu,"Perna, Frank; Agurs-Collins, Tanya",pernafm@mail.nih.gov; collinsta@mail.nih.gov,RFA-CA-21-032; RFA-CA-21-031,,https://enicto.bsc.gwu.edu/web/enicto,,This program focuses on cancer broadly - not limited to a primary cancer type,283432
8/1/2023 14:40,8/1/2023 15:13,IP Address,128.231.234.24,100,1949,TRUE,8/1/2023 15:13,R_2qBCxAnasziFHbn,,,,,39.0462,-77.1195,anonymous,EN,Connecting Underrepresented Populations to Clinical Trials (CUSP2CT),CUSP2CT,"DCC,Health Disparities",CRCHD,,,"Stewart, Whitney; San Miguel-Majors, Sandra L. ",whitney.barfield@nih.gov; sandra.sanmiguel@nih.gov,RFA-CA-21-063; RFA-CA-21-058; RFA-CA-22-014,,https://www.cancer.gov/about-nci/organization/crchd/inp/cusp2ct,https://mayoclinic.elsevierpure.com/en/projects/the-data-evaluation-and-coordination-center-decc-for-connecting-u-2,This program focuses on cancer broadly - not limited to a primary cancer type,858985
8/2/2023 12:56,8/2/2023 12:58,IP Address,128.231.234.26,100,124,TRUE,8/2/2023 12:58,R_21tzV4xoiX11RWm,,,,,39.0462,-77.1195,anonymous,EN,Cancer Prevention Clinical Trials Network (CP-CTNet),CP-CTNet,"DCC,Clinical Networks",DCP,,,"JOHNSEY, DONALD",dj156d@nih.gov,CA-18-030;CA-18-029;CA-19-031,,https://prevention.cancer.gov/major-programs/cancer-prevention-clinical-trials-network-cp-ctnet,https://www.cp-ctnet-dmacc.org/public/program-resources/,This program focuses on cancer broadly - not limited to a primary cancer type,204710
8/3/2023 10:20,8/3/2023 10:26,IP Address,128.231.234.23,100,405,TRUE,8/3/2023 10:26,R_2f7qDkJvnmvumtf,,,,,39.0462,-77.1195,anonymous,EN,City of Hope Lymphoma SPORE,SPORE - Lymphoma,SPORE,DCTD,,,"kuzmin, Igor",kuzmini@mail.nih.gov,,P50CA107399,https://www.cityofhope.org/research/hematologic-malignancies-research-institute/lymphoma-spore,,Lymphoma,549712
8/3/2023 10:27,8/3/2023 12:13,IP Address,128.231.234.23,100,6347,TRUE,8/3/2023 12:13,R_1esL0DW3fEZp3k3,,,,,39.0462,-77.1195,anonymous,EN,Co-Clinical Imaging Research Resource Program,CIRP,"Cancer Moonshot,Clinical Networks",DCTD,,,"ZHANG, HUIMING",zhanghui@mail.nih.gov,PAR-18-841;PAR-16-385;PAR-15-266,,https://ncihub.cancer.gov/groups/cirphub/overview,,This program focuses on cancer broadly - not limited to a primary cancer type,439844
8/7/2023 7:50,8/7/2023 7:50,IP Address,73.130.95.160,100,24,TRUE,8/7/2023 7:50,R_WeZeDjQQcHYcuoV,,,,,40.0756,-76.6914,anonymous,EN,CANCER IMMUNE MONITORING AND ANALYSIS CENTERS,CIMAC,Cancer Moonshot,"CTEP,DCTD",,,"Thurin, Magdalena",thurinm@mail.nih.gov,RFA-CA-17-005;RFA-CA-22-038,,https://dctd.cancer.gov/ResearchNetworks/cimacs_cidc_network.htm,,This program focuses on cancer broadly - not limited to a primary cancer type,163708
8/7/2023 7:51,8/7/2023 7:52,IP Address,73.130.95.160,100,68,TRUE,8/7/2023 7:52,R_33kbsTWRiHV0EX4,,,,,40.0756,-76.6914,anonymous,EN,The Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials (ALCHEMIST),ALCHEMIST,Clinical Networks,DCTD,,,"MOONEY, MARGARET M",mooneym@mail.nih.gov,,U10CA180821;U10CA180830;U10CA031946,https://www.cancer.gov/types/lung/research/alechmist-launch-qa,,Lung Cancer,736643
8/7/2023 7:52,8/7/2023 7:53,IP Address,73.130.95.160,100,64,TRUE,8/7/2023 7:53,R_22YoyYus4QbM740,,,,,40.0756,-76.6914,anonymous,EN,All of Us,,"Pediatric/AYA,DCC",NIH/OD,,help@joinallofus.org,,,HG21-041;LM21-002;MH22-200;OD21-144;OD22-150;OD22-153;OTA17-002;OTA18-001;OTA19-002;OTA19-003;OTA19-004;OTA20-001;OTA20-009;OTA22-006;OTA23-001;OTA23-003;A17-446;PA18-91;PA20-145;PA20-185;PA20-272;PAR20-150;PM23-001;PM23-002;RM21-002;RM21-003;RM21-005;RM21-006;RM21-016;SM18-009;SM21-007;SP20-002,,https://allofus.nih.gov/,,This program focuses on cancer broadly - not limited to a primary cancer type,897986
8/8/2023 7:08,8/8/2023 8:04,IP Address,73.130.95.160,100,3388,TRUE,8/8/2023 8:04,R_1DSWozXfT7QLkA7,,,,,40.0756,-76.6914,anonymous,EN,CTD^2: Cancer Target Discovery and Development,CTD^2,"Pediatric/AYA,DCC",CCG,,,"Komschlies Mcconvill, Kristin",ocg@mail.nih.gov,RFA-CA-16-014;PAR-21-274,,https://ocg.cancer.gov/programs/ctd2,,This program focuses on cancer broadly - not limited to a primary cancer type,325748
8/8/2023 8:10,8/8/2023 8:15,IP Address,73.130.95.160,100,271,TRUE,8/8/2023 8:15,R_25Nm6ltByvx79FB,,,,,40.0756,-76.6914,anonymous,EN,Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant,SPORE - Ovarian,SPORE,DCTD,,,"BASA JANAKIRAM, NAVEENA",naveena.basajanakiram@nih.gov,,P50CA240243,https://trp.cancer.gov/spores/abstracts/dfhcc_ovarian.htm,,Ovarian Cancer,549024
8/8/2023 8:15,8/8/2023 8:16,IP Address,73.130.95.160,100,65,TRUE,8/8/2023 8:16,R_1mDaQLxZWj6BNyB,,,,,40.0756,-76.6914,anonymous,EN,Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer,SPORE - Breast,SPORE,DCTD,,,"BASA JANAKIRAM, NAVEENA",naveena.basajanakiram@nih.gov,,P50CA168504,https://trp.cancer.gov/spores/abstracts/dfhcc_breast.htm,,Breast Cancer,874267
8/9/2023 15:44,8/9/2023 15:50,IP Address,128.231.234.25,100,341,TRUE,8/9/2023 15:50,R_24NTzINm7FcRo8U,,,,,39.0462,-77.1195,anonymous,EN,HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network,CASCADE,"HIV/AIDS,DCC,Clinical Networks",DCP,,,"Sahasrabuddhe, Vikrant",vikrant.sahasrabuddhe@nih.gov,CA-21-045;CA-21-046;CA-21-047;CA-22-051,,https://prevention.cancer.gov/major-programs/hiv-cervical-cancer-prevention-cascade-clinical-trials-network,,Cervical Cancer,884929
8/25/2023 11:05,8/25/2023 13:25,IP Address,73.130.95.160,100,8389,TRUE,8/25/2023 13:25,R_1i2piAKg3ffxFnR,,,,,40.0756,-76.6914,anonymous,EN,ADVANCED DEVELOPMENT OF INFORMATICS TECHNOLOGIES FOR CANCER RESEARCH AND MANAGEMENT,ITCR,"DCC,Clinical Networks",NIH/OD,"Klemm, Juli",,,juli.klemm@nih.gov,PAR15-331;PAR-15-332;PAR15-333;PAR-15-334;RFA-19-040;RFA-20-009;RFA-19-038;RFA-20-007;RFA-19-039;RFA-20-008;RFA-19-041;RFA-20-010;RFA-19-042;RFA-20-060;RFA-21-013;RFA-21-014;RFA-21-015;RFA-21-016;RFA-21-017;RFA-21-018;RFA-21-019;RFA-22-023;RFA-22-021;RFA-22-022;RFA-22-024;RFA-23-014;RFA-23-015;RFA-23-016;RFA-23-017,,https://itcr.cancer.gov/about-itcr,,This program focuses on cancer broadly - not limited to a primary cancer type,751285
8/25/2023 13:26,8/25/2023 13:33,IP Address,73.130.95.160,100,393,TRUE,8/25/2023 13:33,R_2wjhjEFqJLYJw7E,,,,,40.0756,-76.6914,anonymous,EN,Cancer Genome Characterization Initiative,CGCI,DCC,CCG,,,"Komschlies Mcconvill, Kristin",komschkr@mail.nih.gov,,261200800001E-52-0-113;261201500003I-0-26100065-1,https://ocg.cancer.gov/programs/cgci/data-matrix,https://www.cancer.gov/ccg/research/genome-sequencing/cgci/using-cgci,This program focuses on cancer broadly - not limited to a primary cancer type,571292
8/25/2023 13:33,8/25/2023 13:53,IP Address,73.130.95.160,100,1179,TRUE,8/25/2023 13:53,R_3CDj4vrAvM8J9uR,,,,,40.0756,-76.6914,anonymous,EN,Human Tumor Atlas Network,HTAN,"Pediatric/AYA,DCC,Cancer Moonshot",DCP,,,"Shannon Hughes, Ph.D.",Shannon.Hughes@nih.gov,"RFA-CA-17-036;RFA-CA-17-034;RFA-CA-17-035;RFA-CA-20-042, RFA-CA-21-037",,https://humantumoratlas.org/,,This program focuses on cancer broadly - not limited to a primary cancer type,883507
8/28/2023 12:34,8/28/2023 12:48,IP Address,128.231.234.3,100,823,TRUE,8/28/2023 12:48,R_3QPiVYVWjxVEKBy,,,,,39.0042,-77.1075,anonymous,EN,Translational and Basic Science Research in Early Lesions,TBEL,DCC,"DCB,DCP",,,"PATRIOTIS, CHRISTOS F",patriotisc@mail.nih.gov,CA21-055;CA21-054,,Translational and Basic Science Research in Early Lesions (TBEL) - NCI (cancer.gov),,This program focuses on cancer broadly - not limited to a primary cancer type,988344
8/28/2023 12:48,8/28/2023 12:55,IP Address,128.231.234.3,100,407,TRUE,8/28/2023 12:55,R_3lXgzFaZTimjksW,,,,,39.0042,-77.1075,anonymous,EN,ILLUMINATING THE DRUGGABLE GENOME,IDG,DCC,NIH/OD,,,"LI, JERRY",jerry.li@nih.gov,RM16-024;RM16-025;RM16-026,,https://commonfund.nih.gov/idg,https://druggablegenome.net/IDGResourceTables,This program focuses on cancer broadly - not limited to a primary cancer type,890613
8/28/2023 12:55,8/28/2023 13:02,IP Address,128.231.234.3,100,445,TRUE,8/28/2023 13:02,R_12AuW9eEmnPeu14,,,,,39.0042,-77.1075,anonymous,EN,Canine Cancer Immunotherapy Network,K9CIN,DCC,DCTD,,,"SOMMERS, CONNIE L",sommersc@mail.nih.gov,CA21-051;CA21-050,,NCI-funded Canine Immunotherapy Clinical Trials | News & Events | DCTD (cancer.gov),https://caninecommons.cancer.gov/#/,This program focuses on cancer broadly - not limited to a primary cancer type,903936
8/28/2023 13:02,8/28/2023 14:10,IP Address,128.231.234.3,100,4080,TRUE,8/28/2023 14:10,R_2VJGuKHGPo86aQx,,,,,39.0042,-77.1075,anonymous,EN,Cellular Senescence Network,SenNET,DCC,NIH/OD,,,"JHAPPAN, CHAMELLI",jhappanc@mail.nih.gov,RM21-010;RM21-009;RM21-008,,https://sennetconsortium.org/about-2/,https://tristatesennet.pitt.edu/data-analysis-core/,This program focuses on cancer broadly - not limited to a primary cancer type,588833
8/28/2023 14:11,8/28/2023 14:16,IP Address,128.231.234.3,100,335,TRUE,8/28/2023 14:16,R_1LARkgOnijV2Zeu,,,,,39.0042,-77.1075,anonymous,EN,Metabolic Dysregulation and Cancer Risk Program,Metabolic Dysregulation and Cancer Risk Program,"DCC,Clinical Networks","CRCHD,DCB,DCCPS,DCP",,,"LAM, TRAM K",lamt@mail.nih.gov,CA21-022;CA21-021,,https://epi.grants.cancer.gov/metabolic-dysregulation/,,This program focuses on cancer broadly - not limited to a primary cancer type,172493
8/28/2023 14:16,8/28/2023 14:27,IP Address,128.231.234.3,100,610,TRUE,8/28/2023 14:27,R_2qlaEpxG2vMiJq2,,,,,39.0042,-77.1075,anonymous,EN,Participant Engagement and Cancer Genome Sequencing,PE-CGS,Cancer Moonshot,DCCPS,,,"CHOU, WEN-YING",chouws@mail.nih.gov,CA19-046;CA19-045;,,https://epi.grants.cancer.gov/events/pe-cgs/,https://pe-cgs.org/all-research-centers/coordinating-center/,This program focuses on cancer broadly - not limited to a primary cancer type,234765
8/30/2023 12:02,8/30/2023 12:03,IP Address,128.231.234.1,100,61,TRUE,8/30/2023 12:03,R_3hi00xJEDVj2kci,,,,,39.0042,-77.1075,anonymous,EN,Pancreatic Adenocarcinoma Stromal Reprograming ConSortium (PSRC/PASSCODE),PSRC,DCC,"DCB,DCTD","MAITRA, ANIRBAN",amaitra@mdanderson.org,"UJHAZY, PETER",ujhazyp@mail.nih.gov,RFA-CA-21-041; RFA-CA-21-042,,https://www.cancer.gov/about-nci/organization/dcb/research-programs/psrc,,Pancreas Cancer,269405
8/30/2023 12:03,8/30/2023 12:04,IP Address,128.231.234.1,100,27,TRUE,8/30/2023 12:04,R_23Uz9tHRJI24gOj,,,,,39.0042,-77.1075,anonymous,EN,Oncology Models Forum (U24),OMF,"DCC,Cancer Moonshot",DCB,"BUTTE, ATUL J",atul.butte@ucsf.edu,Joanna Watson,watsonjo@mail.nih.gov,PAR14-239; PAR-16-059; PAR-17-245; PAR-20-131,,https://www.cancer.gov/about-nci/organization/dcb/research-programs/omf,,This program focuses on cancer broadly - not limited to a primary cancer type,527035
8/30/2023 12:04,8/30/2023 12:04,IP Address,128.231.234.1,100,11,TRUE,8/30/2023 12:04,R_cZNYPUp9GwdaC9X,,,,,39.0042,-77.1075,anonymous,EN,Pediatric Preclinical in Vivo Testing (PIVOT),PIVOT,"Pediatric/AYA,DCC,Cancer Moonshot","CIB,CTEP,DCTD","BULT, CAROL J",carol.bult@jax.org,"Smith, Malcolm ",Malcolm.Smith@nih.gov,RFA-CA-20-034; RFA-CA-14-018; RFA-CA-20-041,,https://ctep.cancer.gov/MajorInitiatives/Pediatric_PIVOT_Program.htm,,This program focuses on cancer broadly - not limited to a primary cancer type,418157
8/30/2023 12:05,8/30/2023 12:06,IP Address,128.231.234.1,100,14,TRUE,8/30/2023 12:06,R_4N1XriaiDT3au9r,,,,,39.0042,-77.1075,anonymous,EN,Cancer Immunologic Data Commons,CIDC,Cancer Moonshot,DCTD,"CERAMI, ETHAN",cerami@jimmy.harvard.edu,"THURIN, MAGDALENA",thurinm@mail.nih.gov,RFA-CA-17-006; RFA-CA-22-038,,https://dctd.cancer.gov/ResearchNetworks/cimacs_cidc_network.html,,This program focuses on cancer broadly - not limited to a primary cancer type,267552
8/30/2023 12:06,8/30/2023 12:07,IP Address,128.231.234.1,100,19,TRUE,8/30/2023 12:07,R_3Pv3loex4AwbYIJ,,,,,39.0042,-77.1075,anonymous,EN,Childhood Cancer Survivor Study,CCSS,"Pediatric/AYA,DCC,Clinical Networks","CIB,CTEP,DCEG","ARMSTRONG, GREGORY; Seibel, Nita",greg.armstrong@stjude.org; seibelnl@mail.nih.gov,"TIMMER, WILLIAM C.",timmerw@mail.nih.gov,RFA-CA-20-052; RFA-CA15-502,,https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-15-502.html,,This program focuses on cancer broadly - not limited to a primary cancer type,360484
8/30/2023 12:08,8/30/2023 12:08,IP Address,128.231.234.1,100,44,TRUE,8/30/2023 12:08,R_1rJ6XiUlNeQjnwc,,,,,39.0042,-77.1075,anonymous,EN,Pancreatic Cancer Microenvironment Network,PaCMEN,"Cancer Moonshot,Clinical Networks",DCTD,,,"Ujhazy, Peter",ujhazyp@mail.nih.gov,RFA-CA-17-015;Â RFA-CA-17-016,,https://dctd.cancer.gov/NewsEvents/20200102_PaCMEN.htm,,Pancreas Cancer,182188
8/30/2023 12:09,8/30/2023 12:09,IP Address,128.231.234.1,100,9,TRUE,8/30/2023 12:09,R_2bUBBeohm57n68j,,,,,39.0042,-77.1075,anonymous,EN,AIDS and Cancer Specimen Resource (ACSR),ACSR,HIV/AIDS,OHAM,,,Rebecca Liddell Huppi,liddellr@mail.nih.gov,RFA-CA-18-012,,https://acsr1.com/,,,839318
8/30/2023 12:12,8/30/2023 12:13,IP Address,128.231.234.1,100,33,TRUE,8/30/2023 12:13,R_1iso3LVlYiq7Lu7,,,,,39.0042,-77.1075,anonymous,EN,HIV-Associated Malignancy Research Centers,HAMRCs,"HIV/AIDS,Health Disparities",OHAM,,,Geraldina Dominguez,domingug@mail.nih.gov,RFA-CA-20-001; RFA-CA-22-011,,https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/research-africa,,This program focuses on cancer broadly - not limited to a primary cancer type,913832
8/30/2023 12:17,8/30/2023 12:18,IP Address,128.231.234.1,100,80,TRUE,8/30/2023 12:18,R_3iX8DDWxlGziIj3,,,,,39.0042,-77.1075,anonymous,EN,Clinical Proteomic Tumor Analysis Consortium,CPTAC,"Pediatric/AYA,DCC",DCTD,,,"HILTKE, TARA",hiltket@mail.nih.gov,RFA-CA-15-023; RFA-CA-15-021; RFA-CA21-024; RFA-CA21-023,,"https://gdc.cancer.gov/about-gdc/contributed-genomic-data-cancer-research/clinical-proteomic-tumor-analysis-consortium-cptac#:~:text=The%20National%20Cancer%20Institute%27s%20Clinical,and%20genome%20analysis%2C%20or%20proteogenomics.",https://www.icf.com/clients/health/improving-proteomics-data-access-nci,This program focuses on cancer broadly - not limited to a primary cancer type,523792
8/30/2023 12:47,8/30/2023 12:47,IP Address,128.231.234.1,100,14,TRUE,8/30/2023 12:47,R_1OAHLcnbKz3P7bc,,,,,39.0042,-77.1075,anonymous,EN,Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer,SPORE - Gastrointestinal,SPORE,DCTD,,,"NOTHWEHR, STEVEN F",nothwehrs@mail.nih.gov,,P50CA127003,https://trp.cancer.gov/spores/abstracts/dfhcc_gi.htm,,Gastric Cancer,657379
